Login / Signup

Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials.

Julija Gecaite-StoncieneTaryn WilliamsChristine LochnerJacob HoffmanDan J Stein
Published in: Expert opinion on pharmacotherapy (2022)
Two studies provide preliminary evidence in support of citalopram and fluvoxamine for OCPD. Further randomized controlled trials are required before firm conclusions can be drawn regarding efficacy of pharmacotherapy for OCPD.
Keyphrases
  • obsessive compulsive disorder
  • randomized controlled trial
  • smoking cessation
  • open label
  • systematic review
  • clinical trial
  • double blind
  • study protocol
  • placebo controlled
  • meta analyses